Polyclonal Antibody to Monocyte Chemotactic Protein 4 (MCP4)
| Code | Size | Price |
|---|
| PAA216Hu01-20ul | 20ul | £81.00 |
Quantity:
| PAA216Hu01-100ul | 100ul | £149.00 |
Quantity:
| PAA216Hu01-200ul | 200ul | £200.00 |
Quantity:
| PAA216Hu01-1ml | 1ml | £454.00 |
Quantity:
Prices exclude any Taxes / VAT
Overview
Host Type: Rabbit
Antibody Clonality: Polyclonal
Regulatory Status: RUO
Target Species: Human
Applications:
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Immunocytochemistry (ICC)
- Immunohistochemistry- Frozen Section (IHC-F)
- Immunohistochemistry- Paraffin Embedded (IHC-P)
- Western Blot (WB)
Documents
Further Information
Alternative Names:
CCL13; SCYA13; NCC1; SCYL1; CKb10; Chemokine C-C-Motif Ligand 13; Small Inducible Cytokine Subfamily A(Cys-Cys)Member 13; CK-beta-10; Monocyte chemoattractant 4
Buffer Formulation:
PBS, pH7.4, containing 0.02% NaN3, 50% glycerol.
Item Name:
Monocyte Chemotactic Protein 4
Source:
Polyclonal antibody preparation
Usage:
Western blotting: 0.5-2ug/mL;1:360-1340
Immunohistochemistry: 5-20ug/mL;1:36-134
Immunocytochemistry: 5-20ug/mL;1:36-134
Optimal working dilutions must be determined by end user.
Immunohistochemistry: 5-20ug/mL;1:36-134
Immunocytochemistry: 5-20ug/mL;1:36-134
Optimal working dilutions must be determined by end user.
Related Products
| Product Name | Product Code | Supplier | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Immunogen | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Recombinant Monocyte Chemotactic Protein 4 (MCP4) | RPA216Hu01 | Cloud-Clone Corp. | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||